DNA methylation in oral squamous cell carcinoma: Molecular mechanisms and clinical implications

Oral Diseases

Volumn 17, Issue 8, 2011, Pages 771-778

  Gonzalez Ramirez I ^a   Garcia Cuellar C ^a   Sanchez Perez Y ^a   Granados Garcia M ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Biomarker; DNA methylation; Oral carcinoma; Therapy

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; AZACITIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DEATH ASSOCIATED PROTEIN KINASE; DNA; DNA METHYLATION INHIBITOR; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FOLIC ACID; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MULTIVITAMIN; PROTEIN MLH1; UNCLASSIFIED DRUG; UVOMORULIN;

ALCOHOL CONSUMPTION; CANCER GENE THERAPY; CARCINOGENESIS; CPG ISLAND; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA METHYLATION; EPIGENETICS; GENE SILENCING; GENETIC PROCEDURES; GENOTYPE ENVIRONMENT INTERACTION; HEAD AND NECK CARCINOMA; HUMAN; LEUKEMIA; LIFESTYLE; MOLECULAR DYNAMICS; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SMOKING; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; GENE-ENVIRONMENT INTERACTION; HUMANS; MOUTH NEOPLASMS; PROMOTER REGIONS, GENETIC;

EID: 80054087837     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01833.x     Document Type: Review

References (83)

1. Adorjan P, Distler J, Lipscher E et al (2002). Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res 30: e21.
2. Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA et al (2007). Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 120: 2165-2169.
3. Ballestar E, Esteller M (2005). Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger. Biochem Cell Biol 83: 374-384.
4. Ballestar E, Paz MF, Valle L et al (2003). Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 22: 6335-6345.
5. Brieger J, Pongsapich W, Mann SA et al (2010). Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma. Oral Oncol 46: 678-683.
6. Calmon MF, Colombo J, Carvalho F et al (2007). Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet 173: 31-37.
7. Chang HW, Chow V, Lam KY, Wei WI, Yuen A (2002). Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 94: 386-392.
8. Chen J, Xu X (2010). Diet, epigenetic, and cancer prevention. Adv Genet 71: 237-255.
9. Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D (2009). Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Dis 15: 206-213.
10. Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS (2010). Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2: 15.
11. De Schutter H, Geeraerts H, Verbeken E, Nuyts S (2009). Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. Oncol Rep 21: 507-513.
12. Demokan S, Suoglu Y, Demir D, Gozeler M, Dalay N (2006). Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer. Ann Oncol 17: 995-999.
13. Diez-Perez R, Campo-Trapero J, Cano-Sanchez J et al (2011). Methylation in oral cancer and pre-cancerous lesions (Review). Oncol Rep 25: 1203-1209.
14. Doi A, Park IH, Wen B et al (2009). Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41: 1350-1353.
15. Eads CA, Danenberg KD, Kawakami K et al (2000). MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32.
16. Esteller M (2008). Epigenetics in cancer. N Engl J Med 358: 1148-1159.
17. de Freitas Cordeiro-Silva M, Oliveira ZF, de Podesta JR, Gouvea SA, Von Zeidler SV, Louro ID (2011). Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma. Mol Biol Rep. DOI:10.1007/s11033-011-0698-1.
18. Frommer M, McDonald LE, Millar DS et al (1992). A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89: 1827-1831.
19. Gitan RS, Shi H, Chen CM, Yan PS, Huang TH (2002). Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res 12: 158-164.
20. González-Ramírez I, Ramirez-Amador V, Irigoyen-Camacho ME et al (2011). hMLH1 promoter methylation is an early event in oral cancer. Oral Oncol 47: 22-26.
21. Gonzalgo ML, Jones PA (1997). Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res 25: 2529-2531.
22. Gruenbaum Y, Stein R, Cedar H, Razin A (1981). Methylation of CpG sequences in eukaryotic DNA. FEBS Lett 124: 67-71.
23. Guerrero-Preston R, Baez A, Blanco A, Berdasco M, Fraga M, Esteller M (2009). Global DNA methylation: a common early event in oral cancer cases with exposure to environmental carcinogens or viral agents. P R Health Sci J 28: 24-29.
24. Ha PK, Califano JA (2006). Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 7: 77-82.
25. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT (2002). Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 21: 4231-4236.
26. Hashibe M, Brennan P, Chuang SC et al (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18: 541-550.
27. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T (1991). A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci U S A 88: 9523-9527.
28. Hegi ME, Liu L, Herman JG et al (2008). Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26: 4189-4199.
29. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821-9826.
30. Huang MJ, Yeh KT, Shih HC et al (2002). The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas. Int J Mol Med 10: 551-554.
31. Huang TH, Perry MR, Laux DE (1999). Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8: 459-740.
32. Ishida E, Nakamura M, Ikuta M et al (2005). Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. Oral Oncol 41: 614-622.
33. Jones PA, Baylin SB (2007). The epigenomics of cancer. Cell 128: 683-692.
34. Jones PL, Veenstra GJ, Wade PA et al (1998). Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19: 187-191.
35. Kargul J, Laurent GJ (2009). Epigenetics and human disease. Int J Biochem Cell Biol 41: 1.
36. Kato K, Hara A, Kuno T et al (2006). Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. J Cancer Res Clin Oncol 132: 735-743.
37. Kordi-Tamandani DM, Moazeni-Roodi AK, Rigi-Ladiz MA, Hashemi M, Birjandian E, Torkamanzehi A (2010). Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer. Arch Oral Biol 55: 809-814.
38. Kulkarni V, Saranath D (2004). Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol 40: 145-153.
39. Liu K, Huang H, Mukunyadzi P, Suen JY, Hanna E, Fan CY (2002). Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 126: 548-553.
40. Liu K, Zuo C, Luo QK, Suen JY, Hanna E, Fan CY (2003). Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol 12: 50-56.
41. Lopez-Serra L, Ballestar E, Fraga MF, Alaminos M, Setien F, Esteller M (2006). A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res 66: 8342-8346.
42. Machado J, Reis PP, Zhang T et al (2010). Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol 2: 6.
43. Mack GS (2006). Epigenetic cancer therapy makes headway. J Natl Cancer Inst 98: 1443-1444.
44. Marsh D, Suchak K, Moutasim KA et al (2011). Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 223: 470-481.
45. Marsit CJ, Christensen BC, Houseman EA et al (2009). Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 30: 416-422.
46. Maruya S, Issa JP, Weber RS et al (2004). Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res 10: 3825-3830.
47. Mason JB, Choi SW (2005). Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol 35: 235-241.
48. Mathers JC, Strathdee G, Relton CL (2010). Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet 71: 3-39.
49. Meissner A, Mikkelsen TS, Gu H et al (2008). Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770.
50. Nakahara Y, Shintani S, Mihara M, Ueyama Y, Matsumura T (2001). High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas. Cancer Lett 163: 221-228.
51. Ochs K, Kaina B (2000). Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res 60: 5815-5824.
52. Ogi K, Toyota M, Ohe-Toyota M et al (2002). Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 8: 3164-3171.
53. Ohta S, Uemura H, Matsui Y et al (2009). Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107: 81-91.
54. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Reboiras-Lopez MD, Gandara Rey JM, Garcia-Garcia A (2009). Genetic and molecular alterations associated with oral squamous cell cancer (Review). Oncol Rep 22: 1277-1282.
55. Plimack ER, Kantarjian HM, Issa JP (2007). Decitabine and its role in the treatment of hematopoietic malignancies. Leuk Lymphoma 48: 1472-1481.
56. Puri SK, Si L, Fan CY, Hanna E (2005). Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 26: 12-17.
57. Qian XC, Brent TP (1997). Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Cancer Res 57: 3672-3677.
58. Righini CA, de Fraipont F, Timsit JF et al (2007). Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 13: 1179-1185.
59. Rodriguez-Paredes M, Esteller M (2011). Cancer epigenetics reaches mainstream oncology. Nat Med 17: 330-339.
60. Rosas SL, Koch W, da Costa Carvalho MG et al (2001). Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61: 939-942.
61. Ross SA (2010). Evidence for the relationship between diet and cancer. Exp Oncol 32: 137-142.
62. Rudek MA, Zhao M, He P et al (2005). Pharmacokinetics of 5-azacitidine administered with phenylbutyrate in patients with refractory solid tumors or hematologic malignancies. J Clin Oncol 23: 3906-3911.
63. Sanchez-Cespedes M, Esteller M, Wu L et al (2000). Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60: 892-895.
64. Scott JM (1999). Folate and vitamin B12. Proc Nutr Soc 58: 441-448.
65. Scott J, Weir D (1994). Folate/vitamin B12 inter-relationships. Essays Biochem 28: 63-72.
66. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S (2007). Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 109: 703-712.
67. Singer-Sam J, LeBon JM, Tanguay RL, Riggs AD (1990). A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells. Nucleic Acids Res 18: 687.
68. Sharma S, Kelly TK, Jones PA (2010). Epigenetics in cancer. Carcinogenesis 31: 27-36.
69. Shaw R (2006). The epigenetics of oral cancer. Int J Oral Maxillofac Surg 35: 101-108.
70. Smith IM, Mydlarz WK, Mithani SK, Califano JA (2007). DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer 121: 1724-1728.
71. Stidley CA, Picchi MA, Leng S et al (2010). Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Res 70: 568-574.
72. Supic G, Kozomara R, Brankovic-Magic M, Jovic N, Magic Z (2009). Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol 45: 1051-1057.
73. Suzuki MM, Bird A (2008). DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9: 465-476.
74. Taioli E, Ragin C, Wang XH et al (2009). Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer 9: 354.
75. Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM (2011). Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Am J Otolaryngol. DOI.
76. Toyota M, Ho C, Ahuja N et al (1999). Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-2312.
77. Tran TN, Liu Y, Takagi M, Yamaguchi A, Fujii H (2005). Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population. J Oral Pathol Med 34: 150-156.
78. Viswanathan M, Tsuchida N, Shanmugam G (2003). Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 105: 41-46.
79. Xiong Z, Laird PW (1997). COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-2534.
80. Yeh KT, Shih MC, Lin TH et al (2002). The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. Anticancer Res 22: 3971-3975.
81. Yoo CB, Jones PA (2006). Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5: 37-50.
82. von Zeidler SV, Miracca EC, Nagai MA, Birman EG (2004). Hypermethylation of the p16 gene in normal oral mucosa of smokers. Int J Mol Med 14: 807-811.
83. Zuo C, Zhang H, Spencer HJ et al (2009). Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 141: 484-490.